提示: 手机请竖屏浏览!

Electrolyte and Acid–Base Disturbances in Patients with Diabetes Mellitus

Biff F. Palmer ... 糖尿病 • 2015.08.06



Biff F. Palmer, M.D., and Deborah J. Clegg, Ph.D.
From the Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (B.F.P.); and the Biomedical Research Department, Diabetes and Obesity Research Division, Cedars– Sinai Medical Center, Beverly Hills, CA (D.J.C.). Address reprint requests to Dr. Palmer at the Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, or at biff.palmer@utsouthwestern.edu.



1. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta: Centers for Disease Control and Prevention, 2014.

2. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009;32:1335-1343

3. Goguen J, Gilbert J. Hyperglycemic emergencies in adults. Can J Diabetes 2013;37:S72-S76

4. Roscoe JM, Halperin ML, Rolleston FS, Goldstein MB. Hyperglycemia-induced hyponatremia: metabolic considerations in calculation of serum sodium depression. Can Med Assoc J 1975;112:452-453

5. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 1999;106:399-403

6. Nyenwe EA, Kitabchi AE. Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract 2011;94:340-351

7. Kamel KS, Halperin ML. Acid–base problems in diabetic ketoacidosis. N Engl J Med 2015;372:546-554

8. Palmer BF, Gates JR, Lader M. Causes and management of hyponatremia. Ann Pharmacother 2003;37:1694-1702

9. Bustamante M, Hasler U, Kotova O, et al. Insulin potentiates AVP-induced AQP2 expression in cultured renal collecting duct principal cells. Am J Physiol Renal Physiol 2005;288:F334-F344

10. Beukhof CM, Hoorn EJ, Lindemans J, Zietse R. Novel risk factors for hospital-acquired hyponatraemia: a matched case-control study. Clin Endocrinol (Oxf) 2007;66:367-372

11. Liamis G, Liberopoulos E, Barkas F, Elisaf M. Spurious electrolyte disorders: a diagnostic challenge for clinicians. Am J Nephrol 2013;38:50-57

12. Nguyen TQ, Maalouf NM, Sakhaee K, Moe OW. Comparison of insulin action on glucose versus potassium uptake in humans. Clin J Am Soc Nephrol 2011;6:1533-1539

13. Palmer BF. A physiologic-based approach to the evaluation of a patient with hyperkalemia. Am J Kidney Dis 2010;56:387-393

14. Tzamaloukas AH, Ing TS, Elisaf MS, et al. Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: a unique clinical/physiologic exercise in internal potassium balance. Int Urol Nephrol 2010;42:1015-1022

15. Palmer BF. A physiologic-based approach to the evaluation of a patient with hypokalemia. Am J Kidney Dis 2010;56:1184-1190

16. Palmer BF. Regulation of potassium homeostasis. Clin J Am Soc Nephrol 2015;10:1050-1060

17. Aronson PS, Giebisch G. Effects of pH on potassium: new explanations for old observations. J Am Soc Nephrol 2011;22:1981-1989

18. Christensen NJ. Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration. Diabetes 1974;23:1-8

19. Epstein FH, Rosa RM. Adrenergic control of serum potassium. N Engl J Med 1983;309:1450-1451

20. Foster DW, McGarry JD. The metabolic derangements and treatment of diabetic ketoacidosis. N Engl J Med 1983;309:159-169

21. Elisaf MS, Tsatsoulis AA, Katopodis KP, Siamopoulos KC. Acid-base and electrolyte disturbances in patients with diabetic ketoacidosis. Diabetes Res Clin Pract 1996;34:23-27

22. Oh MS, Carroll HJ, Uribarri J. Mechanism of normochloremic and hyperchloremic acidosis in diabetic ketoacidosis. Nephron 1990;54:1-6

23. Adrogué HJ, Eknoyan G, Suki WK. Diabetic ketoacidosis: role of the kidney in the acid-base homeostasis re-evaluated. Kidney Int 1984;25:591-598

24. Mahler SA, Conrad SA, Wang H, Arnold TC. Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis. Am J Emerg Med 2011;29:670-674

25. Halperin ML, Margolis BL, Robinson LA, Halperin RM, West ML, Bear RA. The urine osmolal gap: a clue to estimate urine ammonium in “hybrid” types of metabolic acidosis. Clin Invest Med 1988;11:198-202

26. Halperin ML, Kamel KS. Some observations on the clinical approach to metabolic acidosis Am Soc Nephrol 2010;21:894-897

27. Halperin ML, Vinay P, Gougoux A, Pichette C, Jungas RL. Regulation of the maximum rate of renal ammoniagenesis in the acidotic dog. Am J Physiol 1985;248:F607-F615

28. Halperin ML, Cheema-Dhadli S. Renal and hepatic aspects of ketoacidosis: a quantitative analysis based on energy turnover. Diabetes Metab Rev 1989;5:321-336

29. Cox K, Cocchi MN, Salciccioli JD, Carney E, Howell M, Donnino MW. Prevalence and significance of lactic acidosis in diabetic ketoacidosis. J Crit Care 2012;27:132-137

30. Bolli G, Cartechini MG, Compagnucci P, et al. Adrenergic activity and glycometabolic compensation in patients with diabetes mellitus Minerva Med 1979;70:3783-3795

31. Lu J, Zello GA, Randell E, Adeli K, Krahn J, Meng QH. Closing the anion gap: contribution of D-lactate to diabetic ketoacidosis. Clin Chim Acta 2011;412:286-291

32. Nyenwe EA, Razavi LN, Kitabchi AE, Khan AN, Wan JY. Acidosis: the prime determinant of depressed sensorium in diabetic ketoacidosis. Diabetes Care 2010;33:1837-1839

33. Chua HR, Schneider A, Bellomo R. Bicarbonate in diabetic ketoacidosis — a systematic review. Ann Intensive Care 2011;1:23-23

34. Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA 2014;312:2668-2675

35. Palmer BF. Renal dysfunction complicating the treatment of hypertension. N Engl J Med 2002;347:1256-1261

36. Lalau JD, Andrejak M, Morinière P, et al. Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int J Clin Pharmacol Ther Toxicol 1989;27:285-288

37. Seidowsky A, Nseir S, Houdret N, Fourrier F. Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 2009;37:2191-2196

38. Karet FE. Mechanisms in hyperkalemic renal tubular acidosis. J Am Soc Nephrol 2009;20:251-254

39. Song J, Hu X, Riazi S, Tiwari S, Wade JB, Ecelbarger CA. Regulation of blood pressure, the epithelial sodium channel (ENaC), and other key renal sodium transporters by chronic insulin infusion in rats. Am J Physiol Renal Physiol 2006;290:F1055-F1064

40. Hoorn EJ, Nelson JH, McCormick JA, Ellison DH. The WNK kinase network regulating sodium, potassium, and blood pressure. J Am Soc Nephrol 2011;22:605-614

41. Palmer BF. Managing hyperkalemia caused by inhibitors of the renin–angiotensin–aldosterone system. N Engl J Med 2004;351:585-592

42. Husted FC, Nolph KD, Maher JF. NaHCO3 and NaC1 tolerance in chronic renal failure. J Clin Invest 1975;56:414-419

43. Song Y, Manson JE, Buring JE, Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 2004;27:59-65

44. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007;458:40-47

45. Pham PC, Pham PM, Pham SV, Miller JM, Pham PT. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2007;2:366-373

46. Perazella MA. Proton pump inhibitors and hypomagnesemia: a rare but serious complication. Kidney Int 2013;83:553-556

47. Romani AM. Cellular magnesium homeostasis. Arch Biochem Biophys 2011;512:1-23

48. Goldstein DA, Haldimann B, Sherman D, Norman AW, Massry SG. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function. J Clin Endocrinol Metab 1981;52:116-121

49. McNair P, Christensen MS, Madsbad S, Christiansen C, Transbøl I. Hypoparathyroidism in diabetes mellitus. Acta Endocrinol (Copenh) 1981;96:81-86

50. Schwarz P, Sørensen HA, Momsen G, Friis T, Transbøl I, McNair P. Hypocalcemia and parathyroid hormone responsiveness in diabetes mellitus: a tri-sodium-citrate clamp study. Acta Endocrinol (Copenh) 1992;126:260-263

51. Taylor WH, Khaleeli AA. Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev 2001;17:175-180

52. Palmer BF. Metabolic complications associated with use of diuretics. Semin Nephrol 2011;31:542-552

53. Franks M, Berris RF, et al. Metabolic studies in diabetic acidosis; the effect of the administration of sodium phosphate. Arch Intern Med (Chic) 1948;81:42-55

54. Kebler R, McDonald FD, Cadnapaphornchai P. Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. Am J Med 1985;79:571-576

55. Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 1983;57:177-180

服务条款 | 隐私政策 | 联系我们